UAS regulatory sequences drive expression of a short inverted repeat.
eye, with Scer\GAL4ey.PH
Expressing Nurf-38GL00369 under the control of Scer\GAL4ppl.PU does not significantly affect lipid droplet size in the larval fat body, as compared to controls.
Expression of Nurf-38GL00369 results in: ectopic veins, disrupted posterior wing edge and blisters (with Scer\GAL4en.PU, no phenotype at 18[o]C), increased pupal lethality or strong eye phenotype (with Scer\GAL4ey.PH). Expression driven by Scer\GAL4Act5C.PI is lethal; no overt adult phenotype is observed with either Scer\GAL4GMR.PF or Scer\GAL4nub.PK.
Nurf-38GL00369, Scer\GAL4ppl.PU is a non-suppressor of abnormal size | larval stage phenotype of Scer\GAL4ppl.PU, mrtF931
Nurf-38GL00369, Scer\GAL4fkh.PH, p53UAS.A.Tag:MYC has increased cell death phenotype
Nurf-38GL00369, Scer\GAL4drm.7.1 is an enhancer of terminal tracheal cell | larval stage phenotype of Scer\GAL4drm.7.1, trcGL01127
Nurf-38GL00369, Scer\GAL4ppl.PU is a non-suppressor of embryonic/larval fat body | larval stage phenotype of Scer\GAL4ppl.PU, mrtF931
Nurf-38GL00369, Scer\GAL4ppl.PU is a non-suppressor of lipid droplet | larval stage phenotype of Scer\GAL4ppl.PU, mrtF931
Co-expression of Nurf-38GL00369 and p53Scer\UAS.A.T:Hsap\MYC under the control of Scer\GAL4fkh.PH results in small salivary glands and high levels of apoptotic cell death.